These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1647929)

  • 1. The vaccination and challenge with bovine viral diarrhea virus (BVDV) of calves previously infected with a non-cytopathic BVDV.
    Castrucci G; Frigeri F; Ferrari M; Traldi V
    Comp Immunol Microbiol Infect Dis; 1991; 14(1):31-8. PubMed ID: 1647929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
    Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental contribution to the study of the pathogenesis of bovine viral diarrhea virus infection.
    Castrucci G; Osburn BI; Ferrari M; Traldi V
    Comp Immunol Microbiol Infect Dis; 1992 Jul; 15(3):163-9. PubMed ID: 1325331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid.
    Fulton RW; Step DL; Ridpath JF; Saliki JT; Confer AW; Johnson BJ; Briggs RE; Hawley RV; Burge LJ; Payton ME
    Vaccine; 2003 Jun; 21(21-22):2980-5. PubMed ID: 12798641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K; Schnackel J; Chase CC
    Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of some pathogenetic aspects of bovine viral diarrhea virus infection.
    Castrucci G; Frigeri F; Osburn BI; Ferrari M; Sawyer MM; Aldrovandi V
    Comp Immunol Microbiol Infect Dis; 1990; 13(1):41-9. PubMed ID: 2157576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine.
    Xue W; Mattick D; Smith L; Maxwell J
    Can J Vet Res; 2009 Oct; 73(4):292-7. PubMed ID: 20046631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in circulating lymphocytes and lymphoid tissue associated with vaccination of colostrum deprived calves.
    Falkenberg SM; Dassanayake RP; Palmer MV; Silveira S; Roth JA; Gauger E; Kaiser TJ; Guidarini C; Neill JD; Ridpath JF
    Vaccine; 2020 Oct; 38(46):7268-7277. PubMed ID: 32988689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus.
    Cortese VS; West KH; Hassard LE; Carman S; Ellis JA
    J Am Vet Med Assoc; 1998 Nov; 213(9):1312-9. PubMed ID: 9810390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of humoral and T-cell-mediated immune responses to a single dose of Bovela
    Platt R; Kesl L; Guidarini C; Wang C; Roth JA
    Vet Immunol Immunopathol; 2017 May; 187():20-27. PubMed ID: 28494925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
    J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses.
    Rey MR; Undi M; Rodriguez-Lecompte JC; Joseph T; Morrison J; Yitbarek A; Wittenberg K; Tremblay R; Crow GH; Ominski KH
    Vet J; 2013 Oct; 198(1):235-8. PubMed ID: 24011475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.